HomeRCE • ASX
add
Recce Pharmaceuticals Ltd
Nakaraang pagsara
$0.29
Sakop ng araw
$0.28 - $0.30
Sakop ng taon
$0.28 - $0.66
Market cap
82.19M AUD
Average na Volume
248.44K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 3.47M | 191.69% |
Gastos sa pagpapatakbo | 2.82M | 17.02% |
Net na kita | -3.87M | -3.66% |
Net profit margin | -111.36 | 64.46% |
Kita sa bawat share | — | — |
EBITDA | -3.52M | 2.18% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.94M | -51.51% |
Kabuuang asset | 4.21M | -23.13% |
Kabuuang sagutin | 9.19M | 86.15% |
Kabuuang equity | -4.99M | — |
Natitirang share | 231.87M | — |
Presyo para makapag-book | -14.50 | — |
Return on assets | -210.20% | — |
Return on capital | 3,591.39% | — |
Cash Flow
Net change in cash
| (AUD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -3.87M | -3.66% |
Cash mula sa mga operasyon | -3.46M | -6.24% |
Cash mula sa pag-invest | -203.96K | -190.87% |
Cash mula sa financing | 2.43M | -46.62% |
Net change in cash | -1.24M | -201.00% |
Malayang cash flow | -2.22M | 3.70% |
Tungkol
CEO
Itinatag
Abr 11, 2007
Website
